Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -6 of 6 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Tumor Hypoxia of Head-and-Neck Cancer Underwent Radiation Therapy Measured With F-18-FMISO

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Natural history/Epidemiology, Treatment				Active				18 to 70				Other				HNO-FMISO-FU NCT00180180

Last Modified: 4/24/2008 First Published: 11/12/2007


2.		Phase II Study of Positron Emission Tomography Using Fluoromisonidazole F18 and Fluorodeoxyglucose F18 in Assessing Tumor Hypoxia in Patients Undergoing Therapy for Newly Diagnosed Stage III or IV Cervical Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Diagnostic, Treatment				Active				18 and over				NCI				UW-6143 UW IRB# 6143, 7958, NCT00559377


3.		Study Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography to Detect Hypoxia in Locally Advanced (T3-T4 and./or N1)Primary Rectal Cancer Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Diagnostic				Active				18 and over				Other				07-151 NCT00574353


4.		Validation of 18F-MISO-PET and 18F-FLT-PET

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Diagnostic, Treatment				Active				Over 18				Other				100 NCT00159978


5.		Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography To Detect Hypoxia in Head and Neck Cancer Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Diagnostic				Active				18 and over				Other				04-070 NCT00606294


6.		Hypoxia-Positron Emission Tomography (PET) and Intensity Modulated Proton Therapy (IMPT) Dose Painting in Patients With Chordomas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Diagnostic, Treatment				Active				18 and over				Other				07-162 NCT00713037

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute